CTS

CTS Corporation Announces Date for Fourth Quarter and Full-Year 2023 Earnings Release and Conference Call

Retrieved on: 
星期四, 一月 18, 2024

LISLE, Ill., Jan. 18, 2024 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE: CTS) will release its earnings for the fourth quarter and full-year 2023 at approximately 8:00 a.m. (EST) on Tuesday, February 6, 2024.

Key Points: 
  • LISLE, Ill., Jan. 18, 2024 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE: CTS) will release its earnings for the fourth quarter and full-year 2023 at approximately 8:00 a.m. (EST) on Tuesday, February 6, 2024.
  • A conference call to discuss fourth quarter and full-year 2023 results with management is scheduled for Tuesday, February 6th, 2024 at 10:00 a.m. (EST).
  • The dial-in number for the U.S. (Toll-Free): 1-833-470-1428 (U.S. Local +1 404-975-4839), if calling from outside the U.S., please refer to Global Dial In Numbers to identify the applicable dial-in number for your location.
  • A live audio webcast of the conference call will be available and can be accessed directly from the Investors section of the website of CTS Corporation at https://investors.ctscorp.com/news-events/events-and-presentations/ where it will be archived for one year.

CTS Corporation to Participate in the Needham Growth Conference

Retrieved on: 
星期三, 一月 17, 2024

LISLE, Ill., Jan. 17, 2024 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE: CTS) announced today that Kieran O’Sullivan, President and Chief Executive Officer, will be participating at the 26th Annual Needham Growth Conference on January 17, 2024, at 3:45 PM (EDT).

Key Points: 
  • LISLE, Ill., Jan. 17, 2024 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE: CTS) announced today that Kieran O’Sullivan, President and Chief Executive Officer, will be participating at the 26th Annual Needham Growth Conference on January 17, 2024, at 3:45 PM (EDT).
  • You may access a live webcast of the event using this link or from the Investors section of the CTS Corporation website at www.ctscorp.com.
  • The webcast will also be available for replay on this website for 90 days following the presentation.

DataBee™, from Comcast Technology Solutions, Announces Strategic Technology Partnership with Databricks

Retrieved on: 
星期四, 一月 18, 2024

Comcast Technology Solutions (CTS) today announced that its DataBee business unit, which developed and provides the DataBee security data fabric platform , has signed a strategic technology partnership agreement with Databricks , the Data and AI company.

Key Points: 
  • Comcast Technology Solutions (CTS) today announced that its DataBee business unit, which developed and provides the DataBee security data fabric platform , has signed a strategic technology partnership agreement with Databricks , the Data and AI company.
  • DataBee is now integrated with Databricks’ Data Intelligence Platform, expanding its data lake integrations in keeping with its goal of supporting a customer’s data lake of choice.
  • Thousands of organizations use Databricks’ Data Intelligence Platform to unify their data, analytics and AI initiatives.
  • DataBee 2.0 for the Databricks Data Intelligence Platform is now available on AWS, Microsoft Azure, and Google Cloud Platform (GCP).

Thermo Fisher Scientific Unveils Industry’s First Off-the-Shelf Validated Software Solution to Automate Cell Therapy Manufacturing Workflows

Retrieved on: 
星期三, 一月 17, 2024

To optimize clinical manufacturing processes for innovators developing breakthrough cell therapies, Thermo Fisher Scientific today announced the launch of the Gibco™ Cell Therapy Systems (CTS™) Cellmation™ Software , a first-of-its-kind automation solution designed to connect and integrate workflows across multiple Thermo Fisher Scientific cell therapy instruments while enabling cGMP compliance.

Key Points: 
  • To optimize clinical manufacturing processes for innovators developing breakthrough cell therapies, Thermo Fisher Scientific today announced the launch of the Gibco™ Cell Therapy Systems (CTS™) Cellmation™ Software , a first-of-its-kind automation solution designed to connect and integrate workflows across multiple Thermo Fisher Scientific cell therapy instruments while enabling cGMP compliance.
  • View the full release here: https://www.businesswire.com/news/home/20240117931916/en/
    Gibco Cell Therapy Systems (CTS) Cellmation Software digitally connects instruments from across Thermo Fisher’s cell therapy portfolio to streamline and automate manufacturing.
  • By establishing an automated workflow across multiple stages of cell therapy manufacturing, CTS Cellmation Software helps enable traceability, repeatability and 21 CFR Part 11 compliance with secured data connectivity.
  • At present, CTS Cellmation Software connects core Thermo Fisher Scientific cell therapy instruments, including solutions from our Gibco CTS portfolio.

CTS EVENTIM is the exclusive ticketing partner for the 2027 IHF Men’s World Championship

Retrieved on: 
星期六, 一月 13, 2024

CTS EVENTIM has won contracts for two IHF handball world championships, covering 164 matches and more than 1.3 million tickets.

Key Points: 
  • CTS EVENTIM has won contracts for two IHF handball world championships, covering 164 matches and more than 1.3 million tickets.
  • Dortmund/Hamburg, 12 Jan. 2024 – CTS EVENTIM, a leading international provider of ticketing services and live entertainment, is the official ticketing partner for two major handball tournaments: the 2027 IHF Men’s World Championship and the German matches of the 2025 IHF Women’s World Championship.
  • The 30th IHF Men’s World Championship will be held in 2027.
  • The 27th IHF Women’s World Championship will take place from 27 November to 14 December 2025 in Germany and the Netherlands.

Paragonix SherpaPak Recognized for Maximizing Access to the Donor Pool in New Clinical Study

Retrieved on: 
星期二, 一月 9, 2024

The use of extended criteria donor organs can increase the availability of life-saving transplantable organs, proving to be a valuable solution to those on the waitlist in need of an organ transplant.

Key Points: 
  • The use of extended criteria donor organs can increase the availability of life-saving transplantable organs, proving to be a valuable solution to those on the waitlist in need of an organ transplant.
  • The Paragonix SherpaPak CTS is a static hypothermic preservation device intended to protect the donor heart during transit, standardizing the internal environment to maintain a recommended thermal range above freezing, unlike traditionally used ice-cold storage.
  • Published in the esteemed Journal of Heart and Lung Transplantation, this study compared the effectiveness of ice-cold storage against the Paragonix SherpaPak CTS, assessing the post-transplant outcomes of recipients who received an extended criteria donor heart.
  • “The study finds the Paragonix SherpaPak Cardiac Transport System provides a clinically effective solution to safely increase donor heart utilization.

Converge Announces Next "Coffee and Converge" Event Focused on Re-Imagining Application Modernization

Retrieved on: 
星期五, 一月 5, 2024

The third instalment of the series will be held in downtown Toronto on Tuesday, January 30th at 8:30am Eastern Time.

Key Points: 
  • The third instalment of the series will be held in downtown Toronto on Tuesday, January 30th at 8:30am Eastern Time.
  • The discussion will be hosted by Converge Global CEO and President, Greg Berard and feature Andrew Tenaglia, Vice-President of the Company's Application Modernization Practice.
  • The session will highlight the depth of Application Modernization experience and expertise at Converge by drawing on a diverse set of success stories that demonstrate how Converge strategically approaches each unique engagement.
  • Converge is a leading provider of Application Modernization services across North America.

Converge Announces Next "Coffee and Converge" Event Focused on Re-Imagining Application Modernization

Retrieved on: 
星期五, 一月 5, 2024

The third instalment of the series will be held in downtown Toronto on Tuesday, January 30th at 8:30am Eastern Time.

Key Points: 
  • The third instalment of the series will be held in downtown Toronto on Tuesday, January 30th at 8:30am Eastern Time.
  • The discussion will be hosted by Converge Global CEO and President, Greg Berard and feature Andrew Tenaglia, Vice-President of the Company's Application Modernization Practice.
  • The session will highlight the depth of Application Modernization experience and expertise at Converge by drawing on a diverse set of success stories that demonstrate how Converge strategically approaches each unique engagement.
  • Converge is a leading provider of Application Modernization services across North America.

Attune Announces Partnership with Accuenergy to Optimize Real-Time Energy Monitoring Capabilities in New 'Power Monitoring Kit'

Retrieved on: 
星期四, 一月 4, 2024

VIENNA, Va., Jan. 4, 2024 /PRNewswire/ -- Today, Attune (previously Senseware), the only patented application-ready customizable IoT monitoring technology on the market, announced its partnership with Accuenergy, an internationally renowned sustainable energy metering company, to combine their revenue grade 3-phase meter as well as an 18-channel multi-circuit meter with Attune's wireless data acquisition modules and cloud-based real-time monitoring software in their new Power Monitoring Kits.

Key Points: 
  • As the need for healthy, energy-efficient buildings grows, a plug-and-play wireless energy monitoring kit will help optimize energy and validate the effectiveness of energy conservation initiatives.
  • Manufactured by Accuenergy in its UL508A-certified panel shop, the new Power Monitoring Kit will include Attune's node and bridge sensor components to enable faster lead times and better preparation for large-scale deployments.
  • "This enhanced plug-and-play real-time Energy monitoring solution will now give our customers the most robust data to make decisions, enable ESG reporting, and optimize energy efficiency," said Serene Almomen, CEO and Co-founder of Attune.
  • "We're excited to begin and foster this relationship with Accuenergy and look forward to what we can accomplish together."

VESA Updates Adaptive-Sync Display Standard with New Dual-Mode Support for Emerging Class of Gaming-centric Displays

Retrieved on: 
星期三, 一月 3, 2024

BEAVERTON, Ore., Jan. 3, 2024 /PRNewswire/ -- The Video Electronics Standards Association (VESA®) today announced that it has published an update to its Adaptive-Sync Display Compliance Test Specification (Adaptive-Sync Display CTS), which is the first publicly open standard for front-of-screen performance of variable refresh rate displays. Adaptive-Sync Display version 1.1a provides updated testing procedures and logo support for an emerging category of displays that can operate at different maximum refresh rates when resolution is reduced. This optional "Dual Mode" testing and logo support allows display OEMs with qualifying hardware to certify their products at two different sets of resolution and refresh rate (for example, 4K/144Hz and 1080p/280Hz).

Key Points: 
  • Adaptive-Sync Display version 1.1a provides updated testing procedures and logo support for an emerging category of displays that can operate at different maximum refresh rates when resolution is reduced.
  • Adaptive-Sync Display v1.1a also includes an update that allows display OEMs to achieve a higher AdaptiveSync Display refresh rate certification for displays that support an "overclocked" or faster mode option that is not enabled by default in the factory configuration.
  • Both the dual mode and overclocking changes to the Adaptive-Sync Display CTS v1.1a only apply to the VESA Certified AdaptiveSync Display logo program; they do not apply to the VESA Certified MediaSync Display logo program.
  • To date, more than 100 products have been certified to the Adaptive-Sync Display standard.